Metformin as an emerging concern in wastewater: Occurrence, analysis and treatment methods

A Balakrishnan, M Sillanpää, MM Jacob… - Environmental Research, 2022 - Elsevier
Metformin is a wonder drug used as an anti-hypoglycemic medication; it is also used as a
cancer suppression medicament. Metformin is a first line of drug choice used by doctors for …

Metabolic action of metformin

I Szymczak-Pajor, S Wenclewska, A Śliwińska - Pharmaceuticals, 2022 - mdpi.com
Metformin, a cheap and safe biguanide derivative, due to its ability to influence metabolism,
is widely used as a first-line drug for type 2 diabetes (T2DM) treatment. Therefore, the aim of …

Metformin benefits: another example for alternative energy substrate mechanism?

A Giaccari, A Solini, S Frontoni, S Del Prato - Diabetes Care, 2021 - Am Diabetes Assoc
Since the UK Prospective Diabetes Study (UKPDS), metformin has been considered the first-
line medication for patients with newly diagnosed type 2 diabetes. Though direct evidence …

Metformin in gestational diabetes mellitus: to use or not to use, that is the question

V Tocci, M Mirabelli, A Salatino, L Sicilia, S Giuliano… - Pharmaceuticals, 2023 - mdpi.com
In recent years, there has been a dramatic increase in the number of pregnancies
complicated by gestational diabetes mellitus (GDM). GDM occurs when maternal insulin …

Trilobatin, a natural food additive, exerts anti-type 2 diabetes effect mediated by Nrf2/ARE and IRS-1/GLUT2 signaling pathways

YL Shi, YP Zhang, H Luo, F Xu, JM Gao… - Frontiers in …, 2022 - frontiersin.org
Oxidative stress and aberrant insulin signaling transduction play vital roles in type 2
diabetes mellitus (T2DM). Our previous research has demonstrated that trilobatin (TLB) …

[HTML][HTML] Etiology and management of acute metabolic acidosis: an update

I Matyukhin, S Patschan, O Ritter… - Kidney and Blood …, 2020 - karger.com
Background: The etiology of acute metabolic acidosis (aMA) is heterogeneous, and the
consequences are potentially life-threatening. The aim of this article was to summarize the …

rs622342A> C in SLC22A1 is associated with metformin pharmacokinetics and glycemic response

K Naja, S El Shamieh, R Fakhoury - Drug Metabolism and …, 2020 - Elsevier
Polymorphisms in SLC22A1 lead to variability in metformin clinical efficacy. Sixty-three
Lebanese patients with type 2 diabetes who administered metformin, were followed up for …

Metformin's mechanism of action is stimulation of the biosynthesis of the natural cyclic AMP antagonist prostaglandylinositol cyclic phosphate (cyclic PIP)

HK Wasner - International Journal of Molecular Sciences, 2022 - mdpi.com
Metformin is the leading drug for treating type 2 diabetics, but the mechanism of action of
metformin, despite some suggested mechanisms such as the activation of the AMP-kinase …

[HTML][HTML] Lactic Acidosis Associated with Metformin in Patients with Diabetic Kidney Disease

F Rahman, S Tuba - Medical Archives, 2022 - ncbi.nlm.nih.gov
Background: Diabetes Mellitus is a metabolite disorder with parameters of high blood sugar
levels. In the management of diabetes can be used the drug metformin is the gold of choice …

Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy

L Yang, F Chen, C Gao, J Chen, J Li, S Liu… - Journal of Enzyme …, 2020 - Taylor & Francis
Overexpression of protein tyrosine phosphatase 1B (PTP1B) induces insulin resistance in
various basic and clinical research. In our previous work, a synthetic oleanolic acid (OA) …